Viemed Healthcare Analyst Price Targets

Wall Street analyst price targets and consensus rating for Viemed Healthcare (VMD).

Price Target Range — 1 Quarters

Analyst Consensus — 2 Analysts

1Buy

1Hold

Consensus RatingHold# Analysts2Avg. Consensus PT$13Upside to Avg. PT+29.1%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 24, 2026	Barrington Research	—	Initiate	Outperform	$14
Aug 6, 2026	Freedom Broker	Ilya Zubkov	Downgrade	Buy→Hold	$11

Analyst Ratings News

PRO
Barrington Research Initiates Coverage On Viemed Healthcare with Outperform Rating, Announces Price Target of $14

Barrington Research initiates coverage on Viemed Healthcare (NASDAQ:VMD) with a Outperform rating and announces Price Target of $14.

Benzinga Newsdesk

PRO
RBC Capital Maintains Outperform on Viemed Healthcare, Lowers Price Target to $9

RBC Capital analyst Frank Morgan maintains Viemed Healthcare (NASDAQ:VMD) with a Outperform and lowers the price target from $13 to $9.

Benzinga Newsdesk

Benzinga's Top Ratings Upgrades, Downgrades For March 5, 2021

Benzinga Insights

PRO
RBC Capital Initiates Coverage On Viemed Healthcare with Outperform Rating, Announces Price Target of $13

RBC Capital analyst Anton Hie initiates coverage on Viemed Healthcare (NASDAQ:VMD) with a Outperform rating and announces Price Target of $13.

Benzinga Newsdesk

PRO
Viemed Healthcare Q1 Sales $23.8M, Up 31% YoY

Benzinga Newsdesk

Viemed Healthcare Inc

Viemed Healthcare Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Barrington Research Initiates Coverage On Viemed Healthcare with Outperform Rating, Announces Price Target of $14

PRO
RBC Capital Maintains Outperform on Viemed Healthcare, Lowers Price Target to $9

Benzinga's Top Ratings Upgrades, Downgrades For March 5, 2021

PRO
RBC Capital Initiates Coverage On Viemed Healthcare with Outperform Rating, Announces Price Target of $13

PRO
Viemed Healthcare Q1 Sales $23.8M, Up 31% YoY

People Also Watch

People Also Watch

Viemed Healthcare Inc

Viemed Healthcare Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROBarrington Research Initiates Coverage On Viemed Healthcare with Outperform Rating, Announces Price Target of $14

PRORBC Capital Maintains Outperform on Viemed Healthcare, Lowers Price Target to $9

Benzinga's Top Ratings Upgrades, Downgrades For March 5, 2021

PRORBC Capital Initiates Coverage On Viemed Healthcare with Outperform Rating, Announces Price Target of $13

PROViemed Healthcare Q1 Sales $23.8M, Up 31% YoY

People Also Watch

People Also Watch

PRO
Barrington Research Initiates Coverage On Viemed Healthcare with Outperform Rating, Announces Price Target of $14

PRO
RBC Capital Maintains Outperform on Viemed Healthcare, Lowers Price Target to $9

PRO
RBC Capital Initiates Coverage On Viemed Healthcare with Outperform Rating, Announces Price Target of $13

PRO
Viemed Healthcare Q1 Sales $23.8M, Up 31% YoY